The Fault Line

The Premier League has published its Core Decision on Manchester City. Every charge proved except one. Income overstated by more than £830 million across nine seasons. Commercial agreements found to be shams, through which the club’s owner funded what the accounts recorded as arm’s-length sponsorship. Costs that properly belonged to the club instead borne elsewhere, kept off the books that both the Premier League’s own rules and UEFA’s break-even requirements were built to police. Taken together, the separately stated adjustments exceed £920 million.

That figure is the one that will travel. It is not, however, the finding that matters most. The number people will repeat is the size of the distortion. The finding underneath it is narrower and more consequential: that a Premier League club’s audited accounts did not, for the better part of a decade, give a true and fair view of its finances — and that the competitive framework built around those accounts, spending limits included, was applied throughout that period to numbers that were wrong. City have said they intend to pursue the appeal routes available to them. Nothing here is final.

The compensation question sits alongside it. Four clubs preserved claims in 2024 specifically pending an outcome like this one, with the £35.1 million award a commission ordered Everton to pay Burnley in June — now under appeal — providing the precedent that makes those claims realistic rather than speculative.

Football Finance Briefing — The £920m Financial Finding

What the commission actually found, and why the conclusion on spending limits matters more than the headline distortion figure.

Read the note →

Football Finance Briefing — The Sanction Is Not the Only Big Number

The compensation claims four clubs preserved in 2024, and the Everton precedent that made pursuing them realistic.

Read the note →

Emerging Equities Briefing — Turkey Liquidates as Policy Paths Split

One external constraint, three governments, three different monetary responses.

Read the note →

Frontier Markets Briefing — Oil Splits the Universe as Nigeria Resets

Brent divides exporters from importers along frontier lines, while Nigeria resets a benchmark rather than cutting it.

Read the note →

Oil is pulling in two directions across the frontier universe. Brent settled at $102.59 on 29 September, still up roughly 13% on the month as Saudi Arabia’s damaged East-West pipeline shows early signs of recovery — a gain that favours exporters like Nigeria and Kazakhstan while pushing up inflation and fuel costs for importers such as Sri Lanka and Pakistan. Nigeria’s own 350bp rate move this month belongs to the same story: better read as a realignment of a policy rate that had drifted from market conditions than as conventional easing.

Turkey supplied the week’s largest idiosyncratic shock, with regulators ordering 131 investment funds holding $18.3 billion into liquidation after several managers failed to unwind concentrated positions fast enough under new diversification rules — now escalating into a criminal investigation with five people jailed pending trial.

Monetary policy elsewhere has stopped moving in step. The Fed’s hike to 3.75-4.00% is the shared constraint, but South Africa tightened into fuel pressure, Indonesia held to defend the rupiah, and Hungary held while quietly lowering its 2028 inflation target. Four different responses to one pressure point.

How We Decided What Counts

We rebuilt Bloodstone’s country coverage this week into two universes: Bloodstone Emerging, 23 markets, and Bloodstone Frontier, 22 core markets plus an eight-market Watchlist.

The problem is that nobody agrees. MSCI has South Korea as Emerging; FTSE Russell has it Developed. FTSE treats Peru as Frontier; MSCI treats it as Emerging. The criteria measure accessibility, not development — foreign-ownership limits, convertibility, repatriation rules — which is why China remains the largest constituent of the principal Emerging indices despite its scale.

So we built our own tests: whether a public equity market exists, how deep and liquid it is, how accessible to international investors, and whether it can sustain recurring research. Where providers disagree, we assign on those underlying characteristics rather than preference — Peru sits in Frontier on concentration and liquidity; China and South Korea move to our Asian equities coverage instead of Emerging.

None of this claims the providers got it wrong. They build investable benchmarks that must survive billions tracking them; we organise research coverage. The classifications differ because the purposes do.

Where the Ground Shifts

This week’s stories are about the distance between a label and the thing it describes.

Manchester City is the sharper case. Sponsorship income the commission found was owner funding, costs recorded outside a club that should have sat inside it, related-party relationships not disclosed — and then those audited figures fed into two regulatory systems designed to constrain the behaviour they concealed. The alternative finding should worry anyone reading club accounts: even if the agreements were not shams, the commission found their fair market values very substantially below the recorded figures, and City would still have failed.

The classification work sits on the same axis without the wrongdoing. An index label tells you which rules a market satisfies, not what the market is. Korea is Developed or Emerging depending on whose rulebook you read.

Nigeria makes it a third time: a 350-basis-point move that reads as dramatic easing and isn’t, because the benchmark had drifted from the rates at which money actually changed hands.

The ground does not shift gradually. It holds, and then it moves.

The Fault Line is published weekly by Bloodstone Research, covering macro, commodities, digital assets and the financial structure of sport.

This document is published by Bloodstone Research for informational and institutional research purposes only. It does not constitute investment advice, an investment recommendation, an offer or solicitation to buy or sell any financial instrument, commodity or security, or a forecast of future performance. Market conditions and data may change without notice. Readers should conduct their own analysis and, where appropriate, seek independent professional advice before making investment decisions.

For institutional enquiries: [email protected]